![](/img/cover-not-exists.png)
Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetes
Sykes, A. P., Kemp, G. L., Dobbins, R., O'Connor-Semmes, R., Almond, S. R., Wilkison, W. O., Walker, S., Kler, L.Volume:
17
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12393
Date:
January, 2015
File:
PDF, 499 KB
english, 2015